HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rolf W Sparidans Selected Research

1- O- (2- ((2',6'- dichlorophenyl)amino)phenylacetyl)glucopyranuronic acid

4/2010Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rolf W Sparidans Research Topics

Disease

39Neoplasms (Cancer)
08/2022 - 11/2002
21Breast Neoplasms (Breast Cancer)
01/2021 - 02/2010
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2002
7Neoplasm Metastasis (Metastasis)
01/2019 - 11/2002
6Brain Neoplasms (Brain Tumor)
01/2019 - 11/2012
4Neuroblastoma
03/2018 - 01/2014
3Melanoma (Melanoma, Malignant)
01/2018 - 11/2012
3Colorectal Neoplasms (Colorectal Cancer)
07/2015 - 01/2010
2Leukemia
06/2016 - 02/2016
2Atopic Dermatitis (Atopic Eczema)
02/2012 - 08/2010
2Renal Cell Carcinoma (Grawitz Tumor)
05/2011 - 02/2010
1Diabetic Nephropathies (Diabetic Nephropathy)
05/2022
1Lung Neoplasms (Lung Cancer)
03/2021
1Lymphoma (Lymphomas)
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2019
1Cystinosis
08/2018
1Disease Progression
08/2018
1Philadelphia Chromosome
10/2017
1Glioblastoma (Glioblastoma Multiforme)
03/2017
1Glioma (Gliomas)
03/2017
1Carcinoma (Carcinomatosis)
09/2016
1Retinoblastoma (Glioblastoma, Retinal)
11/2015
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2015
1Inflammation (Inflammations)
01/2015
1Ovarian Neoplasms (Ovarian Cancer)
01/2015
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2015

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2010
18Pharmaceutical PreparationsIBA
08/2022 - 04/2004
15Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021 - 02/2010
7Tyrosine Kinase InhibitorsIBA
06/2020 - 05/2011
6Peptides (Polypeptides)IBA
12/2010 - 01/2010
5Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2010
5Phosphotransferases (Kinase)IBA
01/2022 - 12/2018
5Anaplastic Lymphoma KinaseIBA
03/2019 - 03/2014
4TropomyosinIBA
01/2022 - 12/2018
3larotrectinibIBA
01/2022 - 12/2018
3GemcitabineFDA Link
10/2005 - 11/2002
3Melphalan (Alkeran)FDA LinkGeneric
10/2003 - 11/2002
2cintirorgonIBA
08/2022 - 01/2022
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 04/2004
2selpercatinibIBA
10/2021 - 06/2020
2pralsetinibIBA
10/2021 - 06/2020
2ibrutinibIBA
01/2021 - 11/2018
2lorlatinibIBA
03/2019 - 10/2018
2osimertinibIBA
01/2019 - 09/2016
2ponatinibIBA
10/2017 - 06/2016
2AfatinibIBA
06/2017 - 02/2016
2CrizotinibIBA
12/2015 - 03/2014
24- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
11/2015 - 01/2014
2regorafenibIBA
07/2015 - 10/2014
2EverolimusFDA Link
06/2014 - 08/2012
2ElacridarIBA
03/2014 - 11/2012
2Sorafenib (BAY 43-9006)FDA Link
09/2013 - 02/2010
2Sunitinib (Sutent)FDA Link
09/2013 - 01/2012
2Capecitabine (Xeloda)FDA Link
08/2012 - 07/2006
2Clobetasol (Clobetasol Propionate)FDA LinkGeneric
02/2012 - 08/2010
2Exopeptidases (Exopeptidase)IBA
12/2010 - 08/2010
2Trypsin InhibitorsIBA
12/2010 - 08/2010
2plitidepsin (aplidine)IBA
02/2007 - 06/2005
2TrabectedinIBA
01/2006 - 10/2005
2Cisplatin (Platino)FDA LinkGeneric
10/2005 - 09/2003
1sotorasibIBA
01/2022
1repotrectinibIBA
10/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2021
1Growth Factor ReceptorsIBA
03/2021
1selitrectinibIBA
01/2021
1quizartinibIBA
02/2019
1AZ5104IBA
01/2019
1Agammaglobulinaemia Tyrosine KinaseIBA
11/2018
1Cytochrome P-450 CYP3AIBA
11/2018
1brigatinibIBA
11/2018
1Cystine (L-Cystine)IBA
08/2018
1Cysteamine (Mercaptamine)FDA Link
08/2018
1sepantroniumIBA
03/2018
1Liposomes (Liposome)IBA
03/2018
1SurvivinIBA
03/2018
1encorafenibIBA
01/2018
1MTOR InhibitorsIBA
03/2017
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
03/2017
1ZSTK474IBA
03/2017
1dactolisibIBA
03/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2016
1ceritinibIBA
12/2015
1Cyclin-Dependent Kinase 2IBA
11/2015
1NucleophosminIBA
11/2015
1Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2015
1acetonitrileIBA
03/2015
1dabrafenibIBA
03/2015
1omipalisibIBA
03/2015
1Biological ProductsIBA
01/2015
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2015
1rucaparibIBA
01/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2015
1cadherin 5IBA
01/2015
1CollagenIBA
04/2014

Therapy/Procedure

10Therapeutics
06/2021 - 04/2004
2Aftercare (After-Treatment)
11/2015 - 04/2004
2Oral Administration
03/2015 - 02/2008
1Combined Modality Therapy
11/2015